New Recommendations on Closed Incision Negative Pressure Therapy
Expert guidance sheds light on how reticulated open cell foam (ROCF) dressings enhance patient safety and surgical results.
Solventum™ Prevena™ Therapy stands out as the only closed incision negative pressure therapy system that features fully integrated linear and area dressings specifically designed for closed incisions using ROCF technology.
Recently, an international panel of surgeons and wound care specialists came together to share consensus recommendations on the application of closed incision negative pressure therapy (ciNPT) with ROCF dressings. These important guidelines, published in the International Wound Journal, reflect the transformation of ciNPT from merely an aid for incision management to a fundamental technique adaptable to various surgical procedures that prioritize patient safety across all medical fields.
ciNPT offers significant advantages in managing surgical incisions, especially for patients at greater risk of complications. It operates by applying consistent negative pressure around the incision site, helping to drain excess fluid and alleviate tension. A comprehensive meta-analysis encompassing 84 studies across different surgical specialties revealed that ciNPT remarkably lowers the risks of surgical site complications (SSC), dehiscence, skin necrosis, and hospital readmissions when compared to traditional dressing methods. Its benefits are particularly noteworthy in fields like plastic and reconstructive surgery, orthopedic procedures, trauma care, and more.
Dr. H. John Cooper, an associate professor of orthopedic surgery and part of the study, noted, "ciNPT is a prime example of how a standard of care evolves through evidence and advancements in technology. This consensus highlights the multiple benefits of using ciNPT across diverse surgical specialties to manage high-risk patients effectively."
The advancements in foam dressing designs, such as the expanded coverage provided by Prevena Restor™ Dressings, have widened the applicability of ciNPT to more types of surgical incisions and anatomical situations. This new panel's recommendations specifically address dressing selections, risk evaluations, and essential techniques to enhance application consistency and improve patient outcomes.
A total of 12 recommendations were derived from the panel's thorough review of recent studies and clinical experience with ciNPT using ROCF. By identifying the scenarios where this therapy can provide optimal benefits, these recommendations aim to promote standardized practices for at-risk surgical patients globally. Important highlights include:
Key Highlights of Recommendations
- Risk-based indications: ciNPT dressings utilizing ROCF are ideally suited for patients presenting two or more risk factors, including high-risk incisions for seroma formation, revision surgeries, traumatic wounds, and surgical situations where delayed healing could hinder timely therapeutic interventions.
- Linear vs. area coverage: Area ciNPT dressings are advisable for complex incision patterns, while linear dressings remain the best choice for standard high-tension incisions.
- Integration into protocols: The proactive inclusion of ciNPT in surgical site complication prevention strategies for high-risk patients is encouraged, alongside the utilization of validated incision risk scoring systems.
- Application guidance: The use of hydrocolloid dressings to establish a vacuum seal in challenging locations is recommended.
The panel emphasized that these new recommendations not only focus on immediate surgical needs but also serve as a foundation for impending updates to clinical guidelines. They resonate with findings from a recent global healthcare survey indicating that patient safety remains a top priority for medical professionals worldwide.
Dr. Ryan Egeland, Chief Medical Officer at Solventum, commented, "This international consensus illustrates a shift in the perspective of ciNPT from a selective add-on to a critical component of evidence-based postoperative care. By engaging with our users, we observe innovative applications of our products designed to address various clinical challenges. The Prevena™ Therapy is a prime example of how established medical practices can adapt and progress alongside shifting clinical objectives aimed at improving patient safety and outcomes."
For detailed safety and clinical considerations, please explore more about the Solventum Prevena™ Therapy through their official resources.
About Solventum
Solventum strives to improve healthcare by developing advanced solutions for intricate medical challenges. The company is innovating at the crossroads of health, materials, and data science to create impactful breakthroughs that enhance the quality of patient care and empower healthcare practitioners.
Frequently Asked Questions
What are the main benefits of ciNPT?
ciNPT significantly reduces the risk of surgical site complications, maintains incisional health, and enhances healing conditions for at-risk patients.
How does the new consensus affect surgical procedures?
The consensus offers updated guidelines for incorporating ciNPT into surgical protocols, promoting its use for more complex and high-risk scenarios.
What is ROCF technology?
ROCF technology is a unique foam dressing design that enhances patient outcomes by effectively managing and protecting surgical incisions.
Who are the experts involved in these recommendations?
The recommendations come from an international panel of surgeons and wound care experts specializing in various medical fields.
Where can I learn more about Solventum products?
More information about Solventum's innovative solutions can be accessed through their official website.
